Boston Financial Mangement LLC trimmed its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 34.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,764 shares of the medical technology company’s stock after selling 1,431 shares during the period. Boston Financial Mangement LLC’s holdings in Medtronic were worth $249,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of MDT. Lynx Investment Advisory purchased a new stake in Medtronic in the 2nd quarter worth approximately $28,000. Gleason Group Inc. purchased a new stake in Medtronic in the 2nd quarter worth approximately $42,000. Opal Wealth Advisors LLC purchased a new stake in Medtronic in the 2nd quarter worth approximately $43,000. Olistico Wealth LLC purchased a new stake in Medtronic in the 2nd quarter worth approximately $45,000. Finally, Beacon Capital Management LLC grew its stake in Medtronic by 56.3% in the 2nd quarter. Beacon Capital Management LLC now owns 702 shares of the medical technology company’s stock worth $55,000 after acquiring an additional 253 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.
Medtronic Stock Performance
NYSE:MDT opened at $90.33 on Wednesday. The company has a current ratio of 2.13, a quick ratio of 1.61 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $115.82 billion, a price-to-earnings ratio of 32.85, a PEG ratio of 2.60 and a beta of 0.84. The firm’s fifty day simple moving average is $89.52 and its 200 day simple moving average is $83.98. Medtronic plc has a twelve month low of $68.84 and a twelve month high of $92.68.
Medtronic Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were issued a $0.70 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $2.80 dividend on an annualized basis and a yield of 3.10%. Medtronic’s dividend payout ratio is currently 101.82%.
Analysts Set New Price Targets
Several research firms have commented on MDT. Wells Fargo & Company lifted their target price on shares of Medtronic from $105.00 to $106.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Daiwa America raised shares of Medtronic to a “strong-buy” rating in a research note on Friday, August 23rd. Evercore ISI boosted their price objective on shares of Medtronic from $100.00 to $104.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Robert W. Baird boosted their price objective on shares of Medtronic from $82.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Finally, Oppenheimer boosted their price objective on shares of Medtronic from $92.00 to $94.00 and gave the company a “market perform” rating in a research note on Wednesday, August 21st. One analyst has rated the stock with a sell rating, eight have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $95.36.
Check Out Our Latest Research Report on MDT
Medtronic Profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Featured Stories
- Five stocks we like better than Medtronic
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Stock Sentiment Analysis: How it Works
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.